Catalent plans to expand production of J&J COVID-19 vaccine in Italy - WSJ

Reuters · 03/17/2021 01:04
Catalent plans to expand production of J&J COVID-19 vaccine in Italy - WSJ

- Catalent Inc CTLT.N plans to expand its COVID-19 vaccine production in Europe that will enable it to make more doses of Johnson & Johnson's JNJ.N shot, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

The contract drug manufacturer will bring online a second J&J vaccine production line at its plant in Anagni, Italy, during the fourth quarter, the Journal reported.


(Reporting by Aakriti Bhalla in Bengaluru; editing by Uttaresh.V)

((Aakriti.Bhalla@thomsonreuters.com;))